Position in UTHR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$795,948
+$162,053 QoQ
Shares Held
1,469
+37.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#494
of 870 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EMERALD ADVISERS, LLC holds $22,866,585 across 5 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
608,509 | $21,097,007 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,548 | $831,686 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,469 | $795,948 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
1,256 | $103,971 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
1,049 | $37,973 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $795,948 | 1,469 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $633,895 | 1,069 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $520,870 | 1,069 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $467,838 | 1,116 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $249,132 | 867 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $262,646 | 852 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $674,982 | 1,913 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $692,332 | 1,932 | Shares | Sole | 2024-10-29 | |
| 2023-09-30 | $310,797 | 1,376 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,323,837 | 5,997 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $17,488,140 | 78,086 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $26,263,375 | 94,442 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $19,525,313 | 93,253 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $37,724,314 | 160,093 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $36,484,638 | 203,359 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $40,181,588 | 185,957 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $35,034,576 | 189,807 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $33,632,198 | 187,460 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $32,538,698 | 194,528 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $32,324,287 | 212,954 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $19,489,162 | 192,962 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $23,977,481 | 198,161 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $12,333,305 | 130,057 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||